Real World Study of a Adalimumab Biosimilar (Geleli) in Rheumatoid Arthritis

Safety and Efficacy Study of Adalimumab in Adult Chinese Rheumatoid Arthritis Subjects Treated With Methotrexate

NCT00538902 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Long-term Assessment of Safety and Efficacy of BI 695501 in Patients With Rheumatoid Arthritis

NCT02640612 ·Status: COMPLETED ·Phase: PHASE3

A Study of the Safety and Efficacy of Golimumab (CNTO 148) in Subjects With Active Rheumatoid Arthritis Previously Treated With Biologic Anti-TNFa Agent(s)

NCT00299546 ·Status: COMPLETED ·Phase: PHASE3

A Phase 3 Study Comparing 2 Doses Of CP-690,550 And The Active Comparator, Humira (Adalimumab) Vs. Placebo For Treatment Of Rheumatoid Arthritis

NCT00853385 ·Status: COMPLETED ·Phase: PHASE3

To Evaluate the Efficacy and Safety of Genalumab for Injection in the Treatment of Active Systemic Juvenile Idiopathic Arthritis.

NCT05925452 ·Status: RECRUITING ·Phase: NA

Real-world Effectiveness of Adalimumab on Health Outcomes in Chinese Patients With Immune-Mediated Inflammatory Diseases

NCT03339089 ·Status: COMPLETED

Adalimumab Administered in Korean Rheumatoid Arthritis Subjects Treated With Methotrexate

NCT00235859 ·Status: COMPLETED ·Phase: PHASE3

Real-World Outcome of Adalimumab on Rheumatoid Arthritis Patients in China

NCT02668640 ·Status: COMPLETED

Effectiveness and Safety of Adalimumab in Rheumatoid Arthritis Patients in Routine Clinical Practice

NCT01078090 ·Status: COMPLETED

A Post-Marketing Observational Study to Evaluate the Effectiveness of Adalimumab in Patients With Moderately to Severely Active Rheumatoid Arthritis in China

NCT01464021 ·Status: TERMINATED

Phase Ⅰ Clinical Trial of Gerilimzumab Injection in Healthy Subjects

NCT04178070 ·Status: UNKNOWN ·Phase: PHASE1

Investigation of Immunological and Pharmacological Factors for Response to Adalimumab in Rheumatoid Arthritis

NCT03110094 ·Status: COMPLETED ·Phase: NA

A Long Term Roll-over Study to Investigate the Efficacy and Safety of Adalimumab Given Long-term to Patients With Rheumatoid Arthritis

NCT00233571 ·Status: COMPLETED ·Phase: PHASE3

Study Comparing 80 mg of Adalimumab With Placebo, and Demonstrating the Non-inferiority of Monthly 80 mg Adalimumab Dosing Compared With 40 mg Adalimumab Every Other Week Dosing

NCT00647270 ·Status: COMPLETED ·Phase: PHASE3

A Phase 2 Study For Patients With A Physician's Diagnosis Of Rheumatoid Arthritis

NCT00550446 ·Status: COMPLETED ·Phase: PHASE2

An Open Label Extension Study in Participants With Rheumatoid Arthritis

NCT00837811 ·Status: COMPLETED ·Phase: PHASE2

A Study of Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis

NCT00647491 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

A Study of Adalimumab When Added to Inadequate Standard Anti-rheumatic Therapy in Patients With Active Rheumatoid Arthritis

NCT01231321 ·Status: COMPLETED ·Phase: PHASE3

To Evaluate the Immunogenicity and Safety of Sarilumab Administered as Monotherapy in Patients With Rheumatoid Arthritis (RA)

NCT02121210 ·Status: COMPLETED ·Phase: PHASE3

Study of Subcutaneous Golimumab in Chinese Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy

NCT01248780 ·Status: COMPLETED ·Phase: PHASE3

Study of the Safety and Efficacy of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Moderately to Severely Active Psoriatic Arthritis

NCT00646386 ·Status: COMPLETED ·Phase: PHASE2

BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis

NCT02137226 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Adalimumab in Patients With Active Rheumatoid Arthritis Treated Concomitantly With Methotrexate.

NCT00195702 ·Status: COMPLETED ·Phase: PHASE3

Safety and Effectiveness of Acthar Gel in Participants With Rheumatoid Arthritis

NCT02919761 ·Status: COMPLETED ·Phase: PHASE4

Therapeutic Response to Tumor Necrosis Factor-alpha (TNF-alpha) Antagonists in Rheumatoid Arthritis.

NCT05379049 ·Status: UNKNOWN